However, recent strides in pharmacotherapy have significantly improved management outcomes. The use of immunosuppressive drugs such as calcineurin inhibitors, corticosteroids, mTOR inhibitors, and the ...
Ro, the leading direct-to-patient healthcare company, is set to present new research at The Obesity Society's ObesityWeek 2024 conference in San Antonio, TX. All six of Ro's abstracts, authored by ...